Percutaneous electrical nerve field stimulation compared to standard medical therapy in adolescents with functional abdominal pain disorders

IntroductionStandard medical therapy (SMT) in children with functional abdominal pain disorders (FAPD) includes cyproheptadine and amitriptyline. While percutaneous electrical nerve field stimulation (PENFS) has shown benefit, no study has compared outcomes of PENFS to SMT. We aimed to examine chang...

Full description

Bibliographic Details
Main Authors: Neha R. Santucci, Rashmi Sahay, Khalil I. El-Chammas, Kahleb Graham, Mikaela Wheatley, Madeleine Vandenbrink, Jennifer Hardy, Lin Fei
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Pain Research
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpain.2023.1251932/full
_version_ 1797681400550260736
author Neha R. Santucci
Neha R. Santucci
Rashmi Sahay
Khalil I. El-Chammas
Khalil I. El-Chammas
Kahleb Graham
Kahleb Graham
Mikaela Wheatley
Mikaela Wheatley
Madeleine Vandenbrink
Jennifer Hardy
Lin Fei
author_facet Neha R. Santucci
Neha R. Santucci
Rashmi Sahay
Khalil I. El-Chammas
Khalil I. El-Chammas
Kahleb Graham
Kahleb Graham
Mikaela Wheatley
Mikaela Wheatley
Madeleine Vandenbrink
Jennifer Hardy
Lin Fei
author_sort Neha R. Santucci
collection DOAJ
description IntroductionStandard medical therapy (SMT) in children with functional abdominal pain disorders (FAPD) includes cyproheptadine and amitriptyline. While percutaneous electrical nerve field stimulation (PENFS) has shown benefit, no study has compared outcomes of PENFS to SMT. We aimed to examine changes in abdominal pain, nausea and disability before and after treatment and compare outcomes between treatments.MethodsThe records of FAPD patients ages 11–21 years, treated with 4 weeks of PENFS, cyproheptadine or amitriptyline were reviewed. Outcomes were evaluated using validated questionnaires [Abdominal Pain Index (API), Nausea Severity Scale (NSS), and the Functional Disability Inventory (FDI)] at baseline and follow-up within 3 months (FU).ResultOf 101 patients, 48% received PENFS, 31% cyproheptadine and 21% received amitriptyline. Median ages were 17 (15–19), 16 (15–18) and 15 (11–16) years respectively and the majority were females (75%, 90% and 52% respectively). In the PENFS group, API (p = 0.001), NSS (p = 0.059) and FDI (p = 0.048) were significantly lower at FU. API (p = 0.034) but not NSS and FDI (p > 0.05) decreased significantly at FU in the amitriptyline group. API, NSS and FDI did not change significantly with cyproheptadine at FU (p > 0.05). FU API scores were lower in PENFS vs. cyproheptadine (p = 0.04) but not vs. amitriptyline (p = 0.64). The FDI scores were significantly lower in the amitriptyline vs. cyproheptadine group (p = 0.03).ConclusionTherapy with PENFS showed improvements in abdominal pain, nausea and disability while amitriptyline showed improvements in abdominal pain within 3 months of treatment. PENFS was more effective than cyproheptadine in improving abdominal pain. Amitriptyline improved disability scores more than cyproheptadine and showed promise for treatment. PENFS may be a good non-pharmacologic alternative for FAPD.
first_indexed 2024-03-11T23:44:24Z
format Article
id doaj.art-d494dec128284210a70250304155d6de
institution Directory Open Access Journal
issn 2673-561X
language English
last_indexed 2024-03-11T23:44:24Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pain Research
spelling doaj.art-d494dec128284210a70250304155d6de2023-09-19T15:04:56ZengFrontiers Media S.A.Frontiers in Pain Research2673-561X2023-09-01410.3389/fpain.2023.12519321251932Percutaneous electrical nerve field stimulation compared to standard medical therapy in adolescents with functional abdominal pain disordersNeha R. Santucci0Neha R. Santucci1Rashmi Sahay2Khalil I. El-Chammas3Khalil I. El-Chammas4Kahleb Graham5Kahleb Graham6Mikaela Wheatley7Mikaela Wheatley8Madeleine Vandenbrink9Jennifer Hardy10Lin Fei11Gastroenterology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United StatesPediatrics, University of Cincinnati, Cincinnati, OH, United StatesBiostatistics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United StatesGastroenterology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United StatesPediatrics, University of Cincinnati, Cincinnati, OH, United StatesGastroenterology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United StatesPediatrics, University of Cincinnati, Cincinnati, OH, United StatesGastroenterology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United StatesPediatrics, University of Cincinnati, Cincinnati, OH, United StatesPediatrics, University of Cincinnati, Cincinnati, OH, United StatesGastroenterology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United StatesBiostatistics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United StatesIntroductionStandard medical therapy (SMT) in children with functional abdominal pain disorders (FAPD) includes cyproheptadine and amitriptyline. While percutaneous electrical nerve field stimulation (PENFS) has shown benefit, no study has compared outcomes of PENFS to SMT. We aimed to examine changes in abdominal pain, nausea and disability before and after treatment and compare outcomes between treatments.MethodsThe records of FAPD patients ages 11–21 years, treated with 4 weeks of PENFS, cyproheptadine or amitriptyline were reviewed. Outcomes were evaluated using validated questionnaires [Abdominal Pain Index (API), Nausea Severity Scale (NSS), and the Functional Disability Inventory (FDI)] at baseline and follow-up within 3 months (FU).ResultOf 101 patients, 48% received PENFS, 31% cyproheptadine and 21% received amitriptyline. Median ages were 17 (15–19), 16 (15–18) and 15 (11–16) years respectively and the majority were females (75%, 90% and 52% respectively). In the PENFS group, API (p = 0.001), NSS (p = 0.059) and FDI (p = 0.048) were significantly lower at FU. API (p = 0.034) but not NSS and FDI (p > 0.05) decreased significantly at FU in the amitriptyline group. API, NSS and FDI did not change significantly with cyproheptadine at FU (p > 0.05). FU API scores were lower in PENFS vs. cyproheptadine (p = 0.04) but not vs. amitriptyline (p = 0.64). The FDI scores were significantly lower in the amitriptyline vs. cyproheptadine group (p = 0.03).ConclusionTherapy with PENFS showed improvements in abdominal pain, nausea and disability while amitriptyline showed improvements in abdominal pain within 3 months of treatment. PENFS was more effective than cyproheptadine in improving abdominal pain. Amitriptyline improved disability scores more than cyproheptadine and showed promise for treatment. PENFS may be a good non-pharmacologic alternative for FAPD.https://www.frontiersin.org/articles/10.3389/fpain.2023.1251932/fullneurostimulationamitriptylinecyproheptadinepediatricschronic abdominal pain
spellingShingle Neha R. Santucci
Neha R. Santucci
Rashmi Sahay
Khalil I. El-Chammas
Khalil I. El-Chammas
Kahleb Graham
Kahleb Graham
Mikaela Wheatley
Mikaela Wheatley
Madeleine Vandenbrink
Jennifer Hardy
Lin Fei
Percutaneous electrical nerve field stimulation compared to standard medical therapy in adolescents with functional abdominal pain disorders
Frontiers in Pain Research
neurostimulation
amitriptyline
cyproheptadine
pediatrics
chronic abdominal pain
title Percutaneous electrical nerve field stimulation compared to standard medical therapy in adolescents with functional abdominal pain disorders
title_full Percutaneous electrical nerve field stimulation compared to standard medical therapy in adolescents with functional abdominal pain disorders
title_fullStr Percutaneous electrical nerve field stimulation compared to standard medical therapy in adolescents with functional abdominal pain disorders
title_full_unstemmed Percutaneous electrical nerve field stimulation compared to standard medical therapy in adolescents with functional abdominal pain disorders
title_short Percutaneous electrical nerve field stimulation compared to standard medical therapy in adolescents with functional abdominal pain disorders
title_sort percutaneous electrical nerve field stimulation compared to standard medical therapy in adolescents with functional abdominal pain disorders
topic neurostimulation
amitriptyline
cyproheptadine
pediatrics
chronic abdominal pain
url https://www.frontiersin.org/articles/10.3389/fpain.2023.1251932/full
work_keys_str_mv AT neharsantucci percutaneouselectricalnervefieldstimulationcomparedtostandardmedicaltherapyinadolescentswithfunctionalabdominalpaindisorders
AT neharsantucci percutaneouselectricalnervefieldstimulationcomparedtostandardmedicaltherapyinadolescentswithfunctionalabdominalpaindisorders
AT rashmisahay percutaneouselectricalnervefieldstimulationcomparedtostandardmedicaltherapyinadolescentswithfunctionalabdominalpaindisorders
AT khalilielchammas percutaneouselectricalnervefieldstimulationcomparedtostandardmedicaltherapyinadolescentswithfunctionalabdominalpaindisorders
AT khalilielchammas percutaneouselectricalnervefieldstimulationcomparedtostandardmedicaltherapyinadolescentswithfunctionalabdominalpaindisorders
AT kahlebgraham percutaneouselectricalnervefieldstimulationcomparedtostandardmedicaltherapyinadolescentswithfunctionalabdominalpaindisorders
AT kahlebgraham percutaneouselectricalnervefieldstimulationcomparedtostandardmedicaltherapyinadolescentswithfunctionalabdominalpaindisorders
AT mikaelawheatley percutaneouselectricalnervefieldstimulationcomparedtostandardmedicaltherapyinadolescentswithfunctionalabdominalpaindisorders
AT mikaelawheatley percutaneouselectricalnervefieldstimulationcomparedtostandardmedicaltherapyinadolescentswithfunctionalabdominalpaindisorders
AT madeleinevandenbrink percutaneouselectricalnervefieldstimulationcomparedtostandardmedicaltherapyinadolescentswithfunctionalabdominalpaindisorders
AT jenniferhardy percutaneouselectricalnervefieldstimulationcomparedtostandardmedicaltherapyinadolescentswithfunctionalabdominalpaindisorders
AT linfei percutaneouselectricalnervefieldstimulationcomparedtostandardmedicaltherapyinadolescentswithfunctionalabdominalpaindisorders